Nine Bascom Palmer doctors named to Power List Honoring Top Women in Ophthalmology
News provided by
Share this article
Share this article
MIAMI, April 1, 2021 /PRNewswire/ Nine esteemed ophthalmologists at Bascom Palmer Eye Institute were selected for
The Ophthalmologist Power List 2021, which honors the world s 100 most influential women in the field of ophthalmology.
Audina M. Berrocal, M.D., Hilda Capo, M.D., Janet L. Davis, M.D., M.B.A., Kendall E. Donaldson, M.D., M.S., Anat Galor, M.D., Alana Grajewski, M.D., Ranya G. Habash, M.D., Carol L. Karp, M.D., and Sonia Yoo, M.D., were named to the Power List as published in
Florida International University
Search
Menu
Future FIU docs celebrate early residency matches
All HWCOM medical students who participated were successful in the early match.
February 24, 2021 at 2:00pm
For medical students, graduation is only the beginning of years of training. Next comes residency in their chosen field of specialty. Each year thousands apply to residency programs, but there are more applicants than residency slots. Hence, the process is very competitive and sometimes nerve-wracking.
Match Day, celebrated nationally in March, is when most medical students learn which residency program they have “matched” into. They’ll have to wait until March 19 to find out.
The foremost retinal honor society in the world recognized
Gregg Kokame, chief of ophthalmology and a clinical professor at the University of Hawaiʻi at Manoa John A. Burns School of Medicine (
JABSOM), for his excellence in research of macular diseases. Kokame was awarded the J. Donald M. Gass Medal by the Macula Society, named after one of the worldʻs leading specialists on diseases of the retina who described many different macular diseases.
“To me, the J. Donald M. Gass Medal is the most amazing honor, and one that I would have never thought possible. The Gass Medal is like the Heisman Trophy for retina specialists. I am extremely honored and humbled by this incredible award, which means so much to me, as Dr. Gass meant so much to me,” said Kokame. The Heisman Trophy is awarded to the top college football player each year.
Posted on 7938
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced detailed results from four Phase III studies of its investigational bispecific antibody, faricimab, for the treatment of diabetic macular edema (DME) and neovascular or “wet” age-related macular degeneration (nAMD). The studies consistently showed that faricimab, given at intervals of up to four months, offered non-inferior vision gains compared to aflibercept, given every two months. Approximately half of people eligible for extended dosing with faricimab were able to be treated every four months in the first year in the YOSEMITE and RHINE studies in DME and the TENAYA and LUCERNE studies in nAMD. Faricimab is the first injectable eye medicine to achieve this length of time between treatments in Phase III studies for DME and nAMD. Furthermore, approximately three-quarters of people eligible for extended dosing with far
Michele Abercrombie / NPR
Originally published on January 29, 2021 8:18 pm
Each week, we answer frequently asked questions about life during the coronavirus crisis. If you have a question you d like us to consider for a future post, email us at with the subject line: Weekly Coronavirus Questions.
I m using a lamp that emits UV light in my house to try and kill pathogens the coronavirus in particular. Is it doing any good? And . could exposure to the light be risky for me in any way?
Let s start with the good news: Some recent studies confirm that SARS-CoV-2 is one of the viruses, along with other types of coronaviruses, that can be killed by ultraviolet light rays.